Calvin Sternick

Stock Analyst at JP Morgan

(1.87)
# 3,114
Out of 5,182 analysts
19
Total ratings
38.46%
Success rate
6.19%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $76.57
Upside: +43.66%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $38.17
Upside: +109.59%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $35.20
Upside: -23.30%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $182.41
Upside: -0.22%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $196.64
Upside: -58.81%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $148.97
Upside: +163.14%